153 related articles for article (PubMed ID: 37969442)
1. Clinical implications of forkhead box M1, cyclooxygenase-2
Bai J; Li Y; Cai L
World J Clin Cases; 2023 Oct; 11(30):7284-7293. PubMed ID: 37969442
[TBL] [Abstract][Full Text] [Related]
2. Elevated expression of IRS-1 associates with phosphorylated Akt expression and predicts poor prognosis of breast invasive ductal carcinoma.
Luo J; Feng J; Wen Q; Qoyawayma C; Wang W; Chen L; Lu J; Zhan Y; Xu L; Zang H; Fan S; Chu S
Hum Pathol; 2018 Sep; 79():9-17. PubMed ID: 29551677
[TBL] [Abstract][Full Text] [Related]
3. [p53 protein expression in HER2-negative breast invasive ductal carcinoma].
Qing Z; Zou W; Luo J; Wen Q; Fan S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 39(10):1016-22. PubMed ID: 25355267
[TBL] [Abstract][Full Text] [Related]
4. [Correlation between expression of forkhead box M1 (FOXM1) and clinicopathological features and prognosis in patients with non-small cell lung cancer (NSCLC)].
Liu YQ; Guo RH; Liu LK; Gao W; Zhu CJ; Wei J; Shu YQ
Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):426-30. PubMed ID: 21875482
[TBL] [Abstract][Full Text] [Related]
5. Increased expression of forkhead box M1 is associated with aggressive phenotype and poor prognosis in estrogen receptor-positive breast cancer.
Ahn H; Sim J; Abdul R; Chung MS; Paik SS; Oh YH; Park CK; Jang K
J Korean Med Sci; 2015 Apr; 30(4):390-7. PubMed ID: 25829806
[TBL] [Abstract][Full Text] [Related]
6. Tumor size of breast invasive ductal cancer measured with contrast-enhanced ultrasound predicts regional lymph node metastasis and N stage.
Wang Z; Zhou Q; Liu J; Tang S; Liang X; Zhou Z; He Y; Peng H; Xiao Y
Int J Clin Exp Pathol; 2014; 7(10):6985-91. PubMed ID: 25400785
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive clinicopathological significance and putative transcriptional mechanisms of Forkhead box M1 factor in hepatocellular carcinoma.
Wu HY; Luo LF; Wei F; Jiang HM
World J Surg Oncol; 2023 Nov; 21(1):366. PubMed ID: 38001498
[TBL] [Abstract][Full Text] [Related]
8. Ultrasound Diagnosis of Breast Lymphoma and the Identification of Breast Infiltrating Ductal Carcinoma.
Chen Y; Zhou JH; Fan HX; Luo Y; Peng YL; Ma BY
J Ultrasound Med; 2020 Jun; 39(6):1203-1211. PubMed ID: 31891216
[TBL] [Abstract][Full Text] [Related]
9. A Novel Nomogram Model to Identify Candidates and Predict the Possibility of Benefit From Primary Tumor Resection Among Female Patients With Metastatic Infiltrating Duct Carcinoma of the Breast: A Large Cohort Study.
Wang Z; Chen B; Chen J; Wu Z; Gu H; Wang Y; Dai X
Front Oncol; 2022; 12():798016. PubMed ID: 35237513
[TBL] [Abstract][Full Text] [Related]
10. Increased expression of Forkhead box M1 transcription factor is associated with clinicopathological features and confers a poor prognosis in human hepatocellular carcinoma.
Egawa M; Yoshida Y; Ogura S; Kurahashi T; Kizu T; Furuta K; Kamada Y; Chatani N; Hamano M; Kiso S; Hikita H; Tatsumi T; Eguchi H; Nagano H; Doki Y; Mori M; Takehara T
Hepatol Res; 2017 Oct; 47(11):1196-1205. PubMed ID: 28002884
[TBL] [Abstract][Full Text] [Related]
11. Different molecular subtypes of breast invasive ductal carcinoma.
Zheng LJ; Yang D; Sun LJ; Li SS; Wang JY; Ye SC
J Biol Regul Homeost Agents; 2018; 32(3):553-563. PubMed ID: 29921380
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Forkhead BOX M1 (FOXM1) gene expression in colorectal cancer.
Rather TB; Parveiz I; Bhat GA; Rashid G; Wani RA; Khan IY; Mudassar S
Clin Exp Med; 2023 Oct; 23(6):2385-2405. PubMed ID: 36318377
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Forkhead box M1 protein associates with aggressive tumor features and poor prognosis of hepatocellular carcinoma.
Sun HC; Li M; Lu JL; Yan DW; Zhou CZ; Fan JW; Qin XB; Tang HM; Peng ZH
Oncol Rep; 2011 Jun; 25(6):1533-9. PubMed ID: 21431285
[TBL] [Abstract][Full Text] [Related]
14. Forkhead box M1 (FOXM1) expression predicts disease free survival and may mediate resistance to chemotherapy and hormonotherapy in male breast cancer.
Abdeljaoued S; Bettaieb L; Nasri M; Adouni O; Goucha A; Bouzaiene H; Boussen H; Rahal K; Gamoudi A
Breast Dis; 2018; 37(3):109-114. PubMed ID: 29504520
[TBL] [Abstract][Full Text] [Related]
15. An integrated model of CDCA5 and FOXM1 expression combined with a residual disease that predicts prognosis in ovarian cancer patients.
Zhang Q; Zhang R; Liu M; Wu H; Yang B
Cell Mol Biol (Noisy-le-grand); 2023 Oct; 69(10):143-149. PubMed ID: 37953569
[TBL] [Abstract][Full Text] [Related]
16. From imaging to clinical outcome: dual-region CT radiomics predicting FOXM1 expression and prognosis in hepatocellular carcinoma.
Chen X; Tang Y; Wu D; Li R; Lin Z; Zhou X; Wang H; Zhai H; Xu J; Shi X; Zhang G
Front Oncol; 2023; 13():1278467. PubMed ID: 37817774
[TBL] [Abstract][Full Text] [Related]
17. Forkhead box M1 expression in pulmonary squamous cell carcinoma: correlation with clinicopathologic features and its prognostic significance.
Yang DK; Son CH; Lee SK; Choi PJ; Lee KE; Roh MS
Hum Pathol; 2009 Apr; 40(4):464-70. PubMed ID: 19121844
[TBL] [Abstract][Full Text] [Related]
18. USP22 promotes the G1/S phase transition by upregulating FoxM1 expression via β-catenin nuclear localization and is associated with poor prognosis in stage II pancreatic ductal adenocarcinoma.
Ning Z; Wang A; Liang J; Xie Y; Liu J; Feng L; Yan Q; Wang Z
Int J Oncol; 2014 Oct; 45(4):1594-608. PubMed ID: 24993031
[TBL] [Abstract][Full Text] [Related]
19. Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Ahmed M; Hussain AR; Siraj AK; Uddin S; Al-Sanea N; Al-Dayel F; Al-Assiri M; Beg S; Al-Kuraya KS
Mol Cancer; 2015 Jul; 14():131. PubMed ID: 26159723
[TBL] [Abstract][Full Text] [Related]
20. The forkhead box M1 (FOXM1) expression and antitumor effect of FOXM1 inhibition in malignant rhabdoid tumor.
Shibui Y; Kohashi K; Tamaki A; Kinoshita I; Yamada Y; Yamamoto H; Taguchi T; Oda Y
J Cancer Res Clin Oncol; 2021 May; 147(5):1499-1518. PubMed ID: 33221995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
